Tag:
Baxter International
Latest Headlines
Latest Headlines
Officials spooked by bird flu mix-up
Public health officials in Europe are taking steps to make sure there's no repeat of a recent incident in which the lethal H5N1 virus was accidentally combined with a seasonal flu virus and shipped
Baxter: Vax products contained bird flu virus
Deerfield, IL-based Baxter International has confirmed that vaccine shipments sent to subcontractors in Czech Republic, Slovenia and Germany were contaminated with live H5N1 avian flu viruses. The
Innovative vaccines get EMEA panel approval
Baxter International's H5N1 flu vaccine, Celvapan, received CHMP approval last week, meaning the vaccine could become the first cell culture-based H5N1 influenza vax to hit the market. Celvapan is
Limerick raises $15M; Icahn offered $15B for Biogen; Neogen expands R&D
> Limerick BioPharma has ginned $11 million in venture funds and borrowed $4 million more to advance its work on the bioavailability of drugs. Arch Venture Partners, Sevin Rosen Funds and Altitude
Cell-based pandemic vaccine successful in human trial
Baxter International says that a human trial of its Celvapan bird flu vaccine demonstrated that it spurred an immune response against three strains of the lethal virus. This is the first time that
SPOTLIGHT: Baxter touts Alzheimer's data
Baxter International's Gammagard intravenous plasma-based treatment demonstrated an ability to improve the mental functions of patients with mild moderate Alzheimer's in a small trial. The trial hit
Developers seek alternatives to animal ingredients
The brouhaha over heparin has cast a spotlight on the use of animal products in therapies. It also
ALSO NOTED: Novartis faces development bottleneck; Bayer lowers 2008 expectations;and much more...
> Five years ago Novartis set out to speed drug development, hoping to quickly advance discoveries in the lab to approval. Now the project has been so successful that the company now has a Phase
ALSO NOTED: Shasun sets up NJ plant; Barrier gets a new CEO; Pharming gains grant; and much more...
> India's Shasun Chemicals has set up a processing unit for active pharmaceutical ingredients in New Jersey to supply U.S. customers.
ALSO NOTED: Osiris inks $224M contract; Baxter and Nektar to collaborate;and much more...
> Osiris Therapeutics has inked a deal with the U.S. Defense Department to supply a potential $224 million worth of Prochymal for use in treating military personnel exposed to radiation.
